Caccialanza, Riccardo http://orcid.org/0000-0002-9379-3569
Cereda, Emanuele
Caraccia, Marilisa
Klersy, Catherine
Nardi, Mariateresa
Cappello, Silvia
Borioli, Valeria
Turri, Annalisa
Imarisio, Ilaria
Lasagna, Angioletta
Saddi, Jessica
Arcaini, Luca
Benazzo, Marco
Stragliotto, Silvia
Zagonel, Vittorina
Pedrazzoli, Paolo
Funding for this research was provided by:
Baxter Healthcare Corporation
Akern S.r.l
Akern s.r.l.
Article History
Received: 6 July 2018
Accepted: 23 October 2018
First Online: 1 November 2018
Compliance with ethical standards
: The study was approved by the Institutional Ethics Committee of the Fondazione IRCCS Policlinico San Matteo (Pavia, Italy) and by the Ethics Committee of the Veneto Institute of Oncology-IRCCS (Padova, Italy). It was conducted according to the Declaration of Helsinki. Written informed consent was obtained from each patient.
: RC has received research funding from Baxter Healthcare Corporation. RC and PP have served as consultants and/or on advisory panels for Baxter Healthcare Corporation. RC and PP have participated in speakers’ bureaus for Baxter Healthcare Corporation. RC and EC have participated in speakers’ bureaus for Akern s.r.l.